KIT and gastrointestinal stromal tumor: Interestingly, GIST-48b cells, unlike GIST-882, -T1, and -48 cells, are characterized by no detectable level of the oncoprotein KIT (Figure 5c), suggesting that the mechanism of action of FR2-A was KIT-independent and could provide an alternative treatment to TKIs.